Back to News
Market Impact: 0.15

New Strong Sell Stocks for Dec. 22

AVTRCLCO
Analyst EstimatesAnalyst InsightsCorporate EarningsCompany FundamentalsInvestor Sentiment & PositioningTransportation & Logistics
New Strong Sell Stocks for Dec. 22

Zacks added Avantor (AVTR), Bridgestone (BRDCY) and Cool Company (CLCO) to its Zacks Rank #5 (Strong Sell) list after downward revisions to their current-year earnings estimates over the past 60 days: Avantor -5.3%, Bridgestone -5.1% and Cool Company -6.0%. The combination of a Strong Sell ranking and recent consensus-estimate downgrades signals worsening analyst sentiment and potential downside risk for these names, with Cool Company exposure tied to LNG shipping and Bridgestone tied to tire manufacturing fundamentals.

Analysis

Market structure: The Zacks move to Rank #5 on AVTR and CLCO signals increasing downside risk for smaller-cap, cyclical names versus large incumbents. Direct losers are AVTR (lab consumables exposure to pharma capex) and CLCO (LNG shipping spot/charter weakness); winners are scale providers (Thermo Fisher, TMO) and better-capitalized LNG owners that can outlast a soft freight cycle. Downward 60-day estimate revisions (~5–6%) imply demand softness or pricing pressure rather than isolated misses; expect pressure on equities, widening credit spreads and rising implied vols for these tickers over 1–3 months. Risk assessment: Tail risks include a shipping market collapse from an LNG demand shock (mild-probability, high-impact) or a large customer pullback in biopharma procurement hitting AVTR. Near-term (days–weeks) risks are headline-driven selloffs around earnings; medium-term (3–6 months) risks are weaker charter rates and covenant stress; long-term (12–24 months) depends on R&D spend recovery and vessel orderbook deliveries. Hidden dependency: CLCO’s EBITDA sensitive to spot rates and charter cover; AVTR’s margins hinge on consumables mix and inventory reductions at pharma customers. Trade implications: Favor asymmetric, hedged shorts: buy 3–6 month put spreads on CLCO and AVTR rather than naked shorts to limit funding risk; consider a 2–3% portfolio short position in each name with stop-loss at +20% and target -30% to -50% within 3–6 months. Pair trade idea: short AVTR (2%) vs long TMO (1–2%) to capture relative weakness in smaller lab suppliers; increase cash/IG bond sleeve by 3–5% to buffer volatility. Watch options IV: initiate put spreads when IV > historical 90-day median to monetize elevated fear. Contrarian angles: The market may over-penalize a ~5% earnings revision — not a structural collapse; if LNG winter demand (Nov–Mar) surprises on the upside or AVTR announces cost cuts/divestiture, both stocks can gap higher. Short crowding could create squeeze risk — cap position size and use options. Historical parallel: 2015–2016 shipping troughs delivered fast mean-reversions when demand normalized; a disciplined, time-limited hedge is essential.